Dow's $100 Million Bet on Specialty Silicones

Targeted investments increase product availability, enhance supply chain resilience and accelerate scale-up from innovation to commercialization.

Dow recently announced the advancement of a series of targeted investment projects totaling approximately $100 million by the end of 2027 to expand its global specialty silicones manufacturing and innovation capabilities. These investments reinforce the Company’s commitment to supporting fast-growing end markets while strengthening innovation and supply chain resilience to customers worldwide.

The investments will expand Dow’s specialty silicones capabilities across the United States, China and Japan, focusing on cutting-edge silicones and processing capabilities to meet growing global demand in mobility, electronics and health care applications.

“These investments underscore Dow’s focus on scaling specialty silicones materials and bringing innovation closer and faster to our customers,” said Brendy Lange, President of Performance Materials & Coatings. “By expanding manufacturing and innovation capabilities in these strategic regions, we are investing to meet growing consumer demand, strengthening our global supply chain capabilities, and enabling customers to move faster from innovation to commercialization.”

Investments include:

This completes the series of silicones investments previously disclosed at Dow’s Investor Day event in 2024, with updated timing of the projects reflecting evolving market demand and affordability factors.

Supporting development in High-Value Markets

Demand to specialty silicones continues to grow faster than GDP across mobility, electronics and medical applications, where product performance, supply reliability and technical capabilities are critical. Dow’s investments are designed to support these trends through regional, regional-to-regional manufacturing that aligns capacity with customer demand.

The expanded silicones capacity targets three sectors: mobility (intelligence modules, energy electronics, security systems), electronics (data centers, microelectronics, consumer components), and medical devices, where regional supply chains are increasingly required to regulated items. As the world's largest silicones producer, Dow is building manufacturing close to demand centers across the Americas, Europe, and Asia to shorten the path from production to commercialization.

Dow Chemical Company

Company contact

Enamine's Expert Insights Collection Is Free to Download

Circular Plastics Economy

Safer, Scalable medical Manufacturing with Flow Chemistry

Upcoming Virtual Events

Capillary Electrophoresis in Biotherapeutic research: Platform Methods, Fragment Workflows, and ADC Characterization

complete Insights into Antibody–Drug Conjugates (ADC) to Precision Cancer Therapy

Predictive Simulation in Pharma Production

Operationalizing AI in Polymer research: How Syensqo Is Scaling Impact with the Citrine Platform

Siemens Joins the Global Impact Coalition

Dow to Shut Down Three Upstream European Assets

VCI Welcomes US-EU Customs Deal

Orion Announced Plans to Shut Down Carbon Black vegetation

Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring

Jens Birgersson Becomes New Brenntag CEO

Newsletter & e-edition